The 2025 BFMV Physician Call Coverage Burden and Compensation Survey is in data collection, and findings will be coming soon... You’re invited to take advantage of a $500 early bird discount on access to the survey findings to be released in mid-June. (The regular subscription price is $3,500.) Use 2025EB$500 at checkout in our shop . Offer expires 12:00 NOON EST, June 13, 2025. A 1-Year Subscription to the 2025 BFMV Physician Call Coverage Burden and Compensation Survey Inc

The Department of Justice (DOJ) news page features several noteworthy settlements related to individual physicians involved in alleged medical laboratory kickback schemes. Enforcement action is likely to continue in the medical lab industry, which is upward of $250.9 billion in size and still growing. [1] Physicians who are key to this growth may not realize the extent of their exposure to prosecution in arrangements that seem like win-wins. However, common threads throughou

Work RVUs (wRVUs) are commonly used to measure physician productivity, a ccounting for the technical skills, physical effort, mental effort, judgment, and the amount of time required to perform a given service or procedure. Under many physician compensation plans, a physician is paid a specific dollar amount per wRVU generated. Significant amounts of money may be tied to wRVUs, so it is important that health systems and physicians have confidence that wRVU totals accurately r

Recently, DOJ announced  that pharmaceutical giant Pfizer, on behalf of its subsidiary, Biohaven Pharmaceutical Holding Company Ltd. (“Biohaven”), has agreed to pay nearly $60 million to resolve allegations that Biohaven knowingly caused the submission of false claims to Medicare and other federal health care programs by paying kickbacks to health care providers (“HCPs”) to induce prescriptions of Biohaven’s migraine drug Nurtec ODT before Pfizer acquired the company. The set

New revenue opportunities have opened up for radiology groups with CMS’ extension of flexibilities for the virtual supervision of radiology studies performed with contrast media. The extension allows facilities to provide Level 2 diagnostic tests, including CT and MRI scans, with a remotely located supervising provider through (at least) December 31, 2025. Before the COVID-19 epidemic in 2020, CT and MRI with contrast procedures had to be supervised by onsite physicians who w

The 2025 BFMV Call Coverage survey is   open for data collection . If you are a physician or practice administrator who would like to be included in this useful study, please submit information regarding your unrestricted call coverage arrangement here . Completing the survey takes less than 5 minutes and contributing physicians receive complementary 1-year subscription access to the survey results. Additional information on past BFMV call coverage surveys is available on the